Saama Technologies, Inc. has announced that it has signed a definitive agreement to acquire Comprehend Systems, Inc. This agreement combines Saama and Comprehend’s respective industry positions as clinical data analytics companies. Together, Saama and Comprehend will deploy and evolve their complementary clinical analytics platforms. This agreement creates an opportunity to increase their combined market share, as well as expand their existing partner ecosystems and deliver on a mutual commitment to accelerate clinical development towards unmet patient needs.
“The Comprehend-Saama transaction creates a data analytics powerhouse with a singular vision of improving human health through the application of AI-powered solutions for actionable clinical trial insights,” said Rick Morrison, Founder and Chairman of Comprehend. "The combined 30-plus years of experience of these two companies as data analytics innovators provides exciting opportunities to speed biopharma’s development of new therapeutics and to have broader industry reach.”
“Saama and Comprehend offer life sciences companies and patient-focused organizations the ability to access and optimize a combined ecosystem of unique, state-of-the-art analytics solutions and visualization tools that enable the re-imagination of clinical development and the realization of precision medicine,” said Rebecca Daniels Kush, Ph.D., founder of the Clinical Data Interchange Standards Consortium (CDISC), and member of Saama’s Clinical Board of Advisors.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.